quizartinib
daiichi sankyo
['quizartinib', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'quantum-first']
now having seen results of quantum-first randomized ph3 trial in #eha2022 showing os advantage with quizartinib over placeb when combined with 7+3 for #amlsm with flt3-itd, in what settings would use quizartinib (assuming it gets approved)?
Director-Heme Early Therapeutics & Leader-Leukemia/Myeloid Research @Yale. Personal views. I tweet on cancer, travel, food & soccer. COI: https://t.co/6XkF8CmtrK